Lisa Olson
2022
In 2022, Lisa Olson earned a total compensation of $983.5K as Former Chief Scientific Officer at Dianthus Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $179,760 |
|---|---|
| Option Awards | $373,625 |
| Salary | $428,000 |
| Other | $2,119 |
| Total | $983,504 |
Olson received $428K in salary, accounting for 44% of the total pay in 2022.
Olson also received $179.8K in non-equity incentive plan, $373.6K in option awards and $2.1K in other compensation.
Rankings
In 2022, Lisa Olson's compensation ranked 3,069th out of 5,753 executives tracked by ExecPay. In other words, Olson earned more than 46.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,069 out of 5,753 | 47th |
Division Manufacturing | 1,727 out of 3,133 | 45th |
Major group Chemicals And Allied Products | 811 out of 1,419 | 43rd |
Industry group Drugs | 757 out of 1,320 | 43rd |
Industry Pharmaceutical Preparations | 550 out of 966 | 43rd |
Source: SEC filing on April 11, 2024.
Olson's colleagues
We found two more compensation records of executives who worked with Lisa Olson at Dianthus Therapeutics in 2022.